MILLER STRATEGIES, LLC

Lobbying for ULTRAGENYX PHARMACEUTICAL INC. · Biopharmaceutical company focused on developing novel therapies for rare genetic diseases

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · $140,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Issues relating to rare disease and patient access.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.